Zobrazeno 1 - 10
of 217
pro vyhledávání: '"oral hypoglycemic agent"'
Autor:
Ashish Gautam, Shoor Vir Singh, Ankit Gupta, Anupam Sharma, Saurabh Gupta, Nikhil Pursnani, Prabhat Agrawal
Publikováno v:
Journal of Diabetology, Vol 14, Iss 3, Pp 157-160 (2023)
Background: Despite of several guidelines metformin and glimepiride remains the first prescribed drug in most people with diabetes. Very often canagliflozin and teneligliptin remain the third prescribed OHA. Efficacy of teneligliptin and canagliflozi
Externí odkaz:
https://doaj.org/article/25cc58d4853944449fce81195b22d800
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-7 (2022)
Context: India is an epicenter of type 2 diabetes mellitus (T2DM) in the entire world. Compliance is essential for chronic diseases treatment and has a significant impact on health and health care costs. The current study was planned to assess compli
Externí odkaz:
https://doaj.org/article/de1d7060acd74362a3765b4d721ca3ce
Autor:
Sheng‐Nan Chang, Jien‐Jiun Chen, Pang‐Shuo Huang, Cho‐Kai Wu, Yi‐Chih Wang, Juey‐Jen Hwang, Chia‐Ti Tsai
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 10 (2023)
Background Atrial fibrillation (AF) is associated with increasing risk of thromboembolic or ischemic stroke. The CHA2DS2‐VASc score is a well‐established predictor of AF stroke. Patients with AF have an increased risk of stroke if they have diabe
Externí odkaz:
https://doaj.org/article/5c1bb2a1c4b448cab6a8d17f9691846d
Autor:
Pawankumar Godatwar, Shailesh Deshpande, Sanjay Tamoli, Shishir Pande, Amol Hartalkar, Abhay Kulkarni, Payjani Dubey, Swapnali Mahadik, Vinay Pawar
Publikováno v:
Journal of Ayurveda, Vol 16, Iss 1, Pp 4-10 (2022)
Introduction: Yesaka Liquid is an Ayurvedic Proprietary formulation containing multiple standardized herbal extracts like Triphala (3 myrobalans), Jamun (Eugenia jambolana), Kutki (Picrorhiza kurrooa), Haridra (Curcuma longa) etc., having potential a
Externí odkaz:
https://doaj.org/article/bff6eb788b0b4f6fbb0a2f899c0b2a84
Autor:
Satarupa Dash, Atanu Thakur
Publikováno v:
MGM Journal of Medical Sciences, Vol 9, Iss 1, Pp 61-65 (2022)
Background: Obstructive sleep apnea (OSA) and type 2 diabetes mellitus have a major health impact because of their high prevalence worldwide. Obesity is a common risk factor for both OSA and type 2 diabetes mellitus in middle-aged persons. Aim: This
Externí odkaz:
https://doaj.org/article/88154258c9d54f9c9e5ec05a052f76c1
Publikováno v:
BMC Pregnancy and Childbirth, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background The decision to initiate pharmacotherapy is integral in the care for pregnant women with gestational diabetes mellitus (GDM). We sought to compare pregnancy outcomes between two threshold percentages of elevated glucose values pri
Externí odkaz:
https://doaj.org/article/b52ba8a2cc204d68beda173036abf421
Autor:
Hayato Akimoto, Kotoe Tezuka, Yayoi Nishida, Tomohiro Nakayama, Yasuo Takahashi, Satoshi Asai
Publikováno v:
Pharmacology Research & Perspectives, Vol 7, Iss 6, Pp n/a-n/a (2019)
Abstract Type 2 diabetes mellitus (T2DM) is a risk factor for depression. Since brain insulin resistance plays a potential role in depression, the future risk of depression in patients with T2DM may be altered depending on the class of oral hypoglyce
Externí odkaz:
https://doaj.org/article/bc03e78acd024a7aacb66dd6349d1607
Autor:
Hiroki Nakajima, Sadanori Okada, Takako Mohri, Eiichiro Kanda, Naoyuki Inaba, Yoko Hirasawa, Hiroaki Seino, Hisamoto Kuroda, Toru Hiyoshi, Tetsuji Niiya, Hitoshi Ishii
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 10, Iss 1, Pp 1-11 (2018)
Abstract Background The benefits of sodium glucose cotransporters 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus include plasma glucose control, reduction in body weight and blood pressure, and low risk of hypoglycemia, although they
Externí odkaz:
https://doaj.org/article/ac37bf87a40d4be1a5be0ae3f1d0bbe4
Publikováno v:
Diabetes & Metabolism Journal, Vol 41, Iss 3, Pp 170-178 (2017)
BackgroundThe aim of this study was to investigate the glucose-lowering efficacy of antidiabetic treatments in patients with type 2 diabetes mellitus (T2DM) uncontrolled by sulfonylurea plus metformin.MethodsThis open-label, multicenter, prospective,
Externí odkaz:
https://doaj.org/article/5f49d051fa734f6ba2c8da643ede0dfa